REGULATORY

THU, SEP 12, 2019 09:15 CET

RLS Global signs agreement with OneMed AB

OneMed is one of the Nordic Countries largest distributors within medical technology providing services, support systems and products to the healthcare sector. RLS Global AB has signed a cooperation agreement with OneMed AB who will act as a distributor for ChloraSolv to address the municipalities and county councils with whom they have agreements with for the Nordic countries.

RLS’s sales organization, together with OneMed, will start to build up a structured training program with the aim of giving as many patients as possible access to ChloraSolv. In parallel, RLS continues its evaluation of collaborations with partners in Europe and the rest of the world.

“We are pleased to announce this first step we take in the commercialization of ChloraSolv. We will offer ChloraSolv to both acute and homecare. Together with OneMed, we are opening many doors in the Nordic market to ensure that patients suffering from diabetic foot ulcers gain access to ChoraSolv. OneMed has an impressive distribution network on the Nordic Market.” says Karin Fischer, CEO of RLS Global. “

For more information, please contact:

Karin Fischer, CEO RLS Global AB,
+46 702 48 46 51, karin.fischer@rlsglobal.se

Anders Husmark, CBDO RLS Global AB,
+46 724 50 94 03, anders.husmark@rlsglobal.se

PUBLICATION

This information is information that RLS Global AB (public) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at September 12 at 8.30.

About RLS Global
For many years, RLS Global has worked with oral care specialists, pioneering new therapies for oral care patients. We have now taken another major step toward easier and more effective wound care. We will continue to work with healthcare professionals to develop treatment that helps deliver the best care for each patient. The method is clinically proven and saves the patient a great deal of suffering. Our focus is on caring for patients, developing safe and efficient products that offer gentle treatment methods. We are proud to provide minimally invasive therapy, improving quality of life for patients worldwide. Certified Adviser is Erik Penser Bank, telephone +46 8 463 83 00, Email: certifiedadviser@penser.se. Read more at www.rls.global

Press Release